Loading...
Market
Which region will be the first to receive the MVA-BN vaccine through UN procurement?
2
Resolution / Starting Odds
Africa • 25%
Asia • 25%
Latin America • 25%
Other • 25%
Official announcements from UN agencies and WHO reports
Story
WHO Prequalifies Bavarian Nordic's MVA-BN as First Mpox Vaccine for Emergency Use
Sep 13, 2024, 10:24 AM
The World Health Organization (WHO) has prequalified Bavarian Nordic's MVA-BN vaccine as the first vaccine against mpox. This approval marks a significant step towards expanding access and reducing transmission in high-risk communities, particularly in Africa where the disease has been prevalent. The MVA-BN vaccine, which is also indicated for smallpox, is now eligible for procurement by UN agencies, facilitating broader distribution to those in need. WHO Director-General Dr. Tedros Adhanom Ghebreyesus emphasized the importance of this development in the fight against mpox. The vaccine has been approved for emergency use in adults.
View original story
Similar markets
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
Nigeria • 25%
Kenya • 25%
South Africa • 25%
Other • 25%
Africa • 25%
South America • 25%
Asia • 25%
Other • 25%
Kinshasa • 25%
Katanga • 25%
Kasaï • 25%
Other • 25%
Nigeria • 25%
Kenya • 25%
South Africa • 25%
Democratic Republic of Congo • 25%
WHO • 25%
UNICEF • 25%
African Union • 25%
Other • 25%
Africa • 25%
Asia • 25%
South America • 25%
Other • 25%
Burundi • 25%
DRC • 25%
Kenya • 25%
Other • 25%
Hospitals • 25%
Mobile clinics • 25%
Community centers • 25%
Other • 25%
Southern Africa • 25%
East Africa • 25%
West Africa • 25%
Central Africa • 25%
Africa CDC • 25%
Gavi • 25%
WHO • 25%
Other • 25%
Africa CDC • 25%
WHO • 25%
UNICEF • 25%
Other • 25%